Table 1.
Demography and preoperative characteristics between group I vs. group II
| Data items | Overall population | Group I PCS |
Group II MCS-DST |
P-value |
|---|---|---|---|---|
| N (%) | 64 (100) | 35 (54.6) | 29 (45.4) | - |
| Age (years), median (IQR) | 66 (54–73) | 64 (52.0–72) | 67 (57-74.5) | 0.141 |
| ≥ 60 years | 42 (64%) | 22 (62.9%) | 20 (68.9%) | 0.798 |
| < 60 years | 22 (36%) | 13 (37.1) | 9 (31.1%) | |
| Sex ratio (Female/Male) | 23/41 | 14/21 | 9/20 | 0.602 |
| BMI (kg/m2) Median (IQR) | 26 (23–30) | 26 (21.0-29.5) | 27 (24–30) | 0.283 |
| ASA Score | ||||
| 1 | 17 (26.6%) | 15 (42.9%) | 2 (6.9%) | < 0.001 |
| 2 | 26 (40.6%) | 13 (37.1%) | 13 (44.8%) | |
| 3 | 21 (32.8%) | 7 (20%) | 14 (48.3%) | |
| Comorbidities | ||||
| Renal insufficiancy | 2 (3.1%) | 1 (2.8%) | 1 (3.4%) | 1.000 |
| Cerebral stroke | 3 (4.6%) | 1 (2.8%) | 2 (6.8%) | 0.586 |
| Hepatic insuffisiancy | 1 (2%) | 0 | 1 (3.4%) | 0.453 |
| chronic obstructive pulmonary disease | 1 (2%) | 1 (2.9%) | 0 | 1.000 |
| Peripheric vascular pathology | 1 (2%) | 0 | 1 (3.4%) | 0.453 |
| Previous cancer | 42 (66%) | 17 (48.5%) | 25 (86.2%) | 0.002 |
| Arterial hypertension | 16 | 6 | 10 | 0.150 |
| Cardiac insufficiency | 5 (%) | 1 (2.8%) | 4 (%) | 0.167 |
| Diabetes mellitus | 9 (14%) | 3 (8.6%) | 6 (20.7%) | 0.278 |
| Malignant Colonic Disease | 44 (68.7%) | 19 (54.3%) | 25 (86.2%) | 0.007 |
| Benign Colonic Disease | 20 (31.2%) | 16 (45.7%) | 4 (13.8% | |
| Chronic diverticulitis/Hartman removal | 8 (12.5%) | 4/16 (25%) * | 4/4 (100%) ** | 0.014 |
| Complicated diverticulitis | 12 (18.7%) | 12/16 (75%) | 0 | 0.014 |
| Abscess | 11 (17.2%) | 11/16 (68.5%) | 0 | - |
| Colovesical fistula | 1 (1.5%) | 1/16 (6.2%) | 0 | |
| Colorectal adenocarcinoma location | ||||
| Left colonic cancer | 17/44(38.6%) | 6/19 (31.5%) | 11/25 (44%%) | 0.633 |
| Upper Rectal cancer (10–15 cm AV) | 17/44 (38.6%) | 9/19 (47.4%) | 8/25 (32%) | |
| Mid Rectal cancer (5–10 cm AV) | 10/44(22.3%) | 4/19 (21.1%) | 6/25 (24%) | |
| Neoadjuvant treatment | 16/44 (36.4%) | 6/19 (31.6%) | 10/25 54%) | 0.753 |
| Long course radiochemotherapy | 12/16 (75%) | 4/6 (66%) | 8/10 (80%) | 0.604 |
| Short course of radiotherapy | 4/16 (25%) | 2/6 (37%) | 2/10 (20%) | |
Legend: ASA American Society of Anesthesiologists, AV Anal verge, BMI body mass index, IQR interquartile range
* = (1 x colorectal anastomosis redo, 2 x Hartman restoration after diverticulitis peritonitis, 1 x chronic diverticulitis)
** = (2 x Hartman restoration after diverticulitis peritonitis, 2 x chronic diverticulitis) MCS-DST three-row manual staplers, PCS and two-row power circular staplers